Whole gene expression profile in blood reveals multiple pathways deregulation in R6/2 mouse model.
about
Oligonucleotide-based strategies to combat polyglutamine diseases.Transcription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspectiveSafety, pharmacokinetics, pharmacogenomics and QT concentration-effect modelling of the SirT1 inhibitor selisistat in healthy volunteersEvaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington's DiseaseIntegration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington's disease peripheral blood samplesBioinformatics method identifies potential biomarkers of dilated cardiomyopathy in a human induced pluripotent stem cell-derived cardiomyocyte model.
P2860
Whole gene expression profile in blood reveals multiple pathways deregulation in R6/2 mouse model.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Whole gene expression profile ...... egulation in R6/2 mouse model.
@en
Whole gene expression profile ...... egulation in R6/2 mouse model.
@nl
type
label
Whole gene expression profile ...... egulation in R6/2 mouse model.
@en
Whole gene expression profile ...... egulation in R6/2 mouse model.
@nl
prefLabel
Whole gene expression profile ...... egulation in R6/2 mouse model.
@en
Whole gene expression profile ...... egulation in R6/2 mouse model.
@nl
P2093
P2860
P356
P1433
P1476
Whole gene expression profile ...... egulation in R6/2 mouse model.
@en
P2093
Costanza Fondelli
Daniela Diamanti
Danny Incarnato
Elisa Mori
Federico Malusa
Giuseppe Pollio
Letizia Magnoni
P2860
P2888
P356
10.1186/2050-7771-1-28
P577
2013-10-23T00:00:00Z
P5875
P6179
1021989632